This inventor holds 5 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sanofi. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Oliver Bley: Innovator in Pharmaceutical Formulations
Introduction
Oliver Bley is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stabilized insulin analogues and derivatives. With a total of 5 patents to his name, Bley continues to push the boundaries of innovation in medicine.
Latest Patents
Among his latest patents, Bley has developed stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives. These formulations are crucial for improving the stability and efficacy of insulin treatments. Additionally, he has worked on stabilized pharmaceutical formulations of insulin aspart, which further enhances the therapeutic options available for diabetes management.
Career Highlights
Oliver Bley is currently employed at Sanofi, a global leader in the pharmaceutical industry. His work at Sanofi has allowed him to collaborate with some of the brightest minds in the field, contributing to advancements in diabetes care and treatment.
Collaborations
Bley has had the opportunity to work alongside talented colleagues such as Petra Loos and Bernd Bidlingmaier. Their combined expertise has fostered a collaborative environment that encourages innovation and the development of groundbreaking pharmaceutical solutions.
Conclusion
In summary, Oliver Bley is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact on diabetes treatment. His ongoing contributions and collaborations continue to shape the future of medicine.